Candelanza, Geralyn N.
HRN: 19-09-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2024
METRONIDAZOLE 500MG (TAB)
09/23/2024
09/30/2024
IV
500MG
Q8H
INTRAABDOMINAL INFECTION
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes